Marquess Genetica Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.20 M
- Paid Up Capital ₹ 0.10 M
- Company Age 23 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.45 M
- Revenue Growth -39.41%
- Profit Growth 102.57%
- Ebitda 2655.05%
- Net Worth 0.64%
- Total Assets 20.99%
About Marquess Genetica Pharmaceuticals
Marquess Genetica Pharmaceuticals Private Limited (MGPPL) is a Private Limited Indian Non-Government Company incorporated in India on 14 January 2002 and has a history of 23 years and one month. Its registered office is in Ernakulam, Kerala, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.45 M.
Rajumon Mathew, Wilson Liju, and Raveendran serve as directors at the Company.
Company Details
-
Location
Ernakulam, Kerala, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U51397KL2002PTC015180
-
Company No.
015180
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
14 Jan 2002
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ernakulam
Industry
Who are the key members and board of directors at Marquess Genetica Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajumon Mathew
|
Managing Director | 01-Jun-2013 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Wilson Liju
|
Whole-Time Director | 25-Mar-2014 | Current |
|
Raveendran
|
Whole-Time Director | 25-Mar-2014 | Current |
Financial Performance of Marquess Genetica Pharmaceuticals.
Marquess Genetica Pharmaceuticals Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 39.41% decrease. The company also saw a substantial improvement in profitability, with a 102.57% increase in profit. The company's net worth moved up by a moderate rise of 0.64%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Marquess Genetica Pharmaceuticals?
In 2020, Marquess Genetica Pharmaceuticals had a promoter holding of 72.00% and a public holding of 28.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹2.45 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.25 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 31 Dec 2021 | Canara Bank | ₹0.20 M | Open |
| 26 Jun 2020 | Canara Bank | ₹0.25 M | Open |
| 27 Apr 2017 | Canara Bank | ₹2.00 M | Open |
How Many Employees Work at Marquess Genetica Pharmaceuticals?
Unlock and access historical data on people associated with Marquess Genetica Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Marquess Genetica Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Marquess Genetica Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
